阿佩利斯制药公司
US ˙ NasdaqGS ˙ US03753U1060

介绍

本页面提供了有关 Pascal Deschatelets 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Pascal Deschatelets已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:APLS / Apellis Pharmaceuticals, Inc. Chief Scientific Officer 1,160,496
如何解读这些图表

以下图表显示了在Pascal Deschatelets进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

APLS / Apellis Pharmaceuticals, Inc.内部人士买入 - 短期收益分析

在这一部分,我们分析了在 APLS / Apellis Pharmaceuticals, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

APLS / Apellis Pharmaceuticals, Inc. Insider Trades
APLS / Apellis Pharmaceuticals, Inc.内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 APLS / Apellis Pharmaceuticals, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
2025-01-29 APLS Deschatelets Pascal 826 29.5236 826 29.5236 24,386 106 16.3600 -10,873 -44.59
2025-01-22 APLS Deschatelets Pascal 3,948 30.4255 3,948 30.4255 120,120
2025-01-17 APLS Deschatelets Pascal 750 29.9582 750 29.9582 22,469
2025-01-13 APLS Deschatelets Pascal 2,288 28.7021 2,288 28.7021 65,670
2024-02-12 APLS Deschatelets Pascal 1,148 67.7669 1,148 67.7669 77,796
2024-01-29 APLS Deschatelets Pascal 874 64.1382 874 64.1382 56,057
2024-01-22 APLS Deschatelets Pascal 3,913 64.9960 3,913 64.9960 254,329
2024-01-16 APLS Deschatelets Pascal 1,632 66.8086 1,632 66.8086 109,032
2023-09-08 APLS Deschatelets Pascal 12,000 42.8700 12,000 42.8700 514,440
2021-03-10 APLS Deschatelets Pascal 6,250 50.7400 6,250 50.7400 317,125
2020-02-13 APLS Deschatelets Pascal 55,398 40.9790 55,398 40.9790 2,270,155
2020-02-12 APLS Deschatelets Pascal 52,075 42.8030 52,075 42.8030 2,228,966

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

APLS / Apellis Pharmaceuticals, Inc. Insider Trades
内幕交易历史

该表格显示了由 Pascal Deschatelets 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2025-05-22 2025-05-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 12,780 1,160,496 1.11 3.76 48,053 4,363,465
2025-01-30 2025-01-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -826 1,147,716 -0.07 29.52 -24,386 33,884,708
2025-01-23 2025-01-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -3,948 1,148,542 -0.34 30.43 -120,120 34,944,965
2025-01-21 2025-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 15,045 1,152,490 1.32
2025-01-21 2025-01-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -750 1,137,445 -0.07 29.96 -22,469 34,075,805
2025-01-14 2025-01-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -2,288 1,138,195 -0.20 28.70 -65,670 32,668,587
2024-05-21 2024-05-20 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 24,500 1,140,483 2.20 3.76 92,120 4,288,216
2024-05-09 2024-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 1,115,983 -0.01 44.02 -4,402 49,131,152
2024-05-09 2024-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -22,472 1,116,083 -1.97 42.85 -962,903 47,823,040
2024-05-09 2024-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -56,335 1,138,555 -4.71 42.15 -2,374,543 47,990,549
2024-05-09 2024-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 78,907 1,194,890 7.07 4.31 340,089 5,149,976
2024-04-09 2024-04-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -4,728 1,115,983 -0.42 54.92 -259,639 61,284,430
2024-04-09 2024-04-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -64,379 1,120,711 -5.43 54.12 -3,483,966 60,648,957
2024-04-09 2024-04-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 69,107 1,185,090 6.19 3.76 259,842 4,455,938
2024-03-11 2024-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 1,115,983 -0.01 63.35 -6,335 70,697,523
2024-03-11 2024-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -26,257 1,116,083 -2.30 62.69 -1,646,041 69,966,797
2024-03-11 2024-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -42,750 1,142,340 -3.61 61.88 -2,645,173 70,682,744
2024-03-11 2024-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 69,107 1,185,090 6.19 3.67 253,623 4,349,280
2024-02-13 2024-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -1,148 1,115,983 -0.10 67.77 -77,796 75,626,708
2024-01-31 2024-01-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -874 1,117,131 -0.08 64.14 -56,057 71,650,772
2024-01-23 2024-01-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -3,913 1,118,005 -0.35 65.00 -254,329 72,665,853
2024-01-17 2024-01-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -1,632 1,121,918 -0.15 66.81 -109,032 74,953,771
2024-01-17 2024-01-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 6,743 1,123,550 0.60
2023-11-15 2023-11-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 45,000 1,116,807 4.20 3.76 169,200 4,199,194
2023-11-09 2023-11-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,071,807 -1.11 47.27 -567,240 50,664,317
2023-11-09 2023-11-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 17,494 1,083,807 1.64 2.67 46,709 2,893,765
2023-10-10 2023-10-09 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,066,313 -1.11 40.38 -484,560 43,057,719
2023-10-10 2023-10-09 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,078,313 1.75 2.67 49,395 2,879,096
2023-09-11 2023-09-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -12,000 1,059,813 -1.12 42.87 -514,440 45,434,183
2023-09-11 2023-09-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,071,813 1.76 2.67 49,395 2,861,741
2023-08-09 2023-08-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,053,313 -1.13 23.66 -283,920 24,921,386
2023-08-09 2023-08-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,065,313 1.77 2.67 49,395 2,844,386
2023-07-11 2023-07-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,046,813 -1.13 84.55 -1,014,600 88,508,039
2023-07-11 2023-07-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,058,813 1.78 2.67 49,395 2,827,031
2023-06-09 2023-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,040,313 -1.14 91.35 -1,096,200 95,032,593
2023-06-09 2023-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,052,313 1.79 2.67 49,395 2,809,676
2023-05-09 2023-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,033,813 -1.15 92.39 -1,108,680 95,513,983
2023-05-09 2023-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,045,813 1.80 2.67 49,395 2,792,321
2023-04-11 2023-04-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,027,313 -1.15 78.21 -938,520 80,346,150
2023-04-11 2023-04-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,039,313 1.81 2.67 49,395 2,774,966
2023-03-10 2023-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,020,813 -1.16 63.79 -765,480 65,117,661
2023-03-10 2023-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,032,813 1.82 2.67 49,395 2,757,611
2023-02-22 2023-02-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -1,195 1,014,313 -0.12 58.50 -69,908 59,337,310
2023-02-22 2023-02-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 9,886 1,015,508 0.98
2023-02-14 2023-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -1,134 1,005,622 -0.11 51.21 -58,072 51,497,903
2023-02-10 2023-02-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,006,756 -1.18 54.45 -653,400 54,817,864
2023-02-10 2023-02-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,018,756 1.85 2.67 49,395 2,720,079
2023-01-30 2023-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -832 1,000,256 -0.08 52.77 -43,905 52,783,509
2023-01-24 2023-01-20 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -2,326 1,001,088 -0.23 52.05 -121,068 52,106,630
2023-01-17 2023-01-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 19,634 1,003,414 2.00
2023-01-10 2023-01-09 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 983,780 -1.21 46.08 -552,960 45,332,582
2023-01-10 2023-01-09 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 995,780 1.89 2.67 49,395 2,658,733
2022-12-30 2022-12-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 7,000 977,280 0.72 3.67 25,690 3,586,618
2022-12-12 2022-12-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 970,280 -1.22 47.50 -570,000 46,088,300
2022-12-12 2022-12-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 982,280 1.92 2.67 49,395 2,622,688
2022-11-10 2022-11-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 963,780 -1.23 46.47 -557,640 44,786,857
2022-11-10 2022-11-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 975,780 1.93 2.67 49,395 2,605,333
2022-10-11 2022-10-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 957,280 -1.24 57.50 -690,000 55,043,600
2022-10-11 2022-10-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 969,280 1.95 2.67 49,395 2,587,978
2022-09-12 2022-09-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 950,780 -1.25 63.98 -767,760 60,830,904
2022-09-12 2022-09-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 962,780 1.96 2.67 49,395 2,570,623
2022-08-09 2022-08-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 944,280 -1.25 62.50 -750,000 59,017,500
2022-08-09 2022-08-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 956,280 1.97 2.67 49,395 2,553,268
2022-07-12 2022-07-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 937,780 -1.26 47.95 -575,400 44,966,551
2022-07-12 2022-07-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,500 949,780 0.69 2.67 17,355 2,535,913
2022-07-12 2022-07-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 12,000 943,280 1.29 2.67 32,040 2,518,558
2022-06-22 2022-06-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 33,005 931,280 3.67 2.67 88,123 2,486,518
2022-06-09 2022-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,500 898,275 0.73 2.67 17,355 2,398,394
2022-06-09 2022-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 891,775 -1.33 44.09 -529,080 39,318,360
2022-06-09 2022-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 12,000 903,775 1.35 2.67 32,040 2,413,079
2022-05-02 2022-04-29 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -4,000 364,999 -1.08
2022-05-02 2022-04-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -4,000 891,775 -0.45 44.43 -177,720 39,621,563
2022-05-02 2022-04-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 4,000 895,775 0.45 2.67 10,680 2,391,719
2022-05-02 2022-04-21 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
J - Other -11,250 0 -100.00
2022-05-02 2022-04-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
J - Other -1,875 891,775 -0.21
2022-02-14 2022-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -1,057 893,650 -0.12 47.12 -49,806 42,108,788
2022-02-01 2022-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -931 894,707 -0.10 38.59 -35,927 34,526,743
2022-01-25 2022-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 36,951 36,951
2022-01-25 2022-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 26,051 895,638 3.00
2021-06-25 2021-06-24 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,250 368,999 -1.67
2021-06-25 2021-06-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,250 869,587 -0.71 65.61 -410,062 57,053,603
2021-06-25 2021-06-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,250 875,837 0.72 2.67 16,688 2,338,485
2021-05-25 2021-05-24 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,250 375,249 -1.64
2021-05-25 2021-05-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,250 869,587 -0.71 47.40 -296,250 41,218,424
2021-05-25 2021-05-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,250 875,837 0.72 2.67 16,688 2,338,485
2021-04-29 2021-04-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -4,500 381,499 -1.17
2021-04-29 2021-04-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 4,500 869,587 0.52 2.67 12,015 2,321,797
2021-04-26 2021-04-23 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,250 385,999 -1.59
2021-04-26 2021-04-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,250 865,087 -0.72 46.13 -288,312 39,906,463
2021-04-26 2021-04-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,250 871,337 0.72 2.67 16,688 2,326,470
2021-03-11 2021-03-10 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -6,250 392,249 -1.57
2021-03-11 2021-03-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -6,250 865,087 -0.72 50.74 -317,125 43,894,514
2021-03-11 2021-03-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 6,250 871,337 0.72 2.67 16,688 2,326,470
2021-02-11 2021-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -688 865,087 -0.08 47.72 -32,831 41,281,952
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 11,250 11,250
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 45,000 45,000
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 1,875 865,775 0.22
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 7,500 863,900 0.88
2020-03-12 2020-03-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift -161,656 847,025 -16.03
2020-02-14 2020-02-13 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -117,205 0 -100.00
2020-02-14 2020-02-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -55,398 1,008,681 -5.21 40.98 -2,270,155 41,334,739
2020-02-14 2020-02-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 117,205 1,064,079 12.38 2.14 250,819 2,277,129
2020-02-14 2020-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -117,206 117,205 -50.00
2020-02-14 2020-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -52,075 946,874 -5.21 42.80 -2,228,966 40,529,048
2020-02-14 2020-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 117,206 998,949 13.29 2.14 250,821 2,137,751
2020-02-12 2020-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Stock option (right to buy)
A - Award 56,250 56,250
2020-02-12 2020-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 9,375 891,118 1.06
2019-09-26 2019-09-25 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,010 881,743 -0.11 25.64 -25,897 22,608,772
2019-09-26 2019-09-25 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -20,531 882,753 -2.27 25.24 -518,161 22,278,920
2019-09-25 2019-09-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,295 903,284 -0.14 24.96 -32,321 22,544,162
2019-09-25 2019-09-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -20,307 904,579 -2.20 24.56 -498,760 22,217,365
2019-09-25 2019-09-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 924,886 -0.01 25.53 -2,553 23,612,340
2019-09-25 2019-09-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -20,758 924,986 -2.19 25.07 -520,362 23,187,549
2019-02-12 2019-02-08 4 APLS Apellis Pharmaceuticals, Inc.
Stock option (right to buy)
A - Award 95,000 95,000
2018-05-09 2018-05-07 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
J - Other 384,292 945,744 68.45
2018-02-21 2018-02-16 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 110,000 110,000
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock
1,122,904
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock
1,122,904
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)